Company: APXIF
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065703
Chunk: 282

Company: APx Acquisition Corp. I
Filing Date: 2025-07-18
Form: F-4/A
Chunk 282
---
 which would become the final holding company. Among the main material terms of the first draft of the Business Combination Agreement, the draft included customary representations and warranties applicable to the Company, SPAC, MultiplAI, Merger Sub and Merger Sub2, and specific representations and warranties undertaken by the Company and SPAC, such as: (i) compliance with applicable laws, ensuring that neither entity is subject to ongoing violations that would have a material adverse effect; (ii) ownership of tangible and intangible assets, confirming good title without liens except for permitted ones; (iii) the accuracy of financial statements, prepared in compliance with international standards and fairly presented the financial position of the Company and SPAC; (iv) tax -relatedrepresentations ensuring timely filing and payment of taxes, (v) intellectual property assertions by the Company guaranteeing sole ownership or valid license to all necessary intellectual property; and (vi) absence of benefit plans across the Company and its subsidiaries. In addition, the first draft of the Business Combination Agreement included joint covenants applicable to all parties, such as: (i) the use of reasonable commercial efforts to obtain necessary regulatory approvals and cooperation with Governmental Authorities; (ii) the preparation and filing of the Proxy/Registration Statement with the SEC; (iii) the holding of shareholder meetings by SPAC and the Company to secure approval for transaction -relatedproposals and achieve necessary consents; (iv) the execution of all legally required filings and notifications to consummate the transaction; and (v) confidentiality maintenance with mutual approval required for public announcements unless legally mandated. On February 6, 2024, Greenberg sent comments to the Business Combination Agreement to Linklaters, reflecting an implied target enterprise valuation of $300,000,000 for OmnigenicsAI and $40,000,000 for MultiplAI, proposing additional representations and warranties and covenants applicable to the Company and MultiplAI, as well modifications to the termination provisions. Also on February 6, Linklaters, Greenberg, Pérez Alati, Grondona, Benites & Arntsen, Argentine counsel to APx (“Pérez”), and representatives from MultiplAI conducted a diligence call in respect of MultiplAI. On February 7, 2024, the parties to the Heritas LOI amended its terms to extend the exclusivity period contained within. On February 9, 2024, Linklaters, Greenberg, Pérez and representatives from Heritas Argentina conducted a